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Abstract: Celecoxib, diclofenac, ibuprofen, and nimesulide are nonsteroidal anti-inflammatory 
drugs (NSAIDs) very commonly used for the treatment of moderate to mild pain, together with 
paracetamol (acetaminophen), a very widely used analgesic with a lesser anti-inflammatory 
effect. In the study reported here, we tested the efficacy of celecoxib, diclofenac, and ibuprofen 
on preprotachykinin mRNA synthesis, substance P (SP) release, prostaglandin E
2
 (PGE
2
) release, 
and protein kinase C epsilon (PKCε) translocation in rat cultured sensory neurons from dorsal root 
ganglia (DRGs). The efficacy of these NSAIDs was compared with the efficacy of paracetamol 
and nimesulide in in vitro models of hyperalgesia (investigated previously). While nimesulide 
and paracetamol, as in previous experiments, decreased the percentage of cultured DRG neurons 
showing translocation of PKCε caused by 100 nM thrombin or 1 µM bradykinin in a dose-
dependent manner, the other NSAIDs tested did not have a significant effect. The amount of 
SP released by peptidergic neurons and the expression level of preprotachykinin mRNA were 
assessed in basal conditions and after 70 minutes or 36 hours of stimulation with an inflammatory 
soup (IS) containing potassium chloride, thrombin, bradykinin, and endothelin-1. The release 
of SP at 70 minutes was inhibited only by nimesulide, while celecoxib and diclofenac were 
effective at 36 hours. The mRNA basal level of the SP precursor preprotachykinin expressed 
in DRG neurons was reduced only by nimesulide, while the increased levels expressed during 
treatment with the IS were significantly reduced by all drugs tested, with the exception of 
ibuprofen. All drugs were able to decrease basal and IS-stimulated PGE
2
 release. Our study 
demonstrates novel mechanisms of action of commonly used NSAIDS.
Keywords: PKCε, nociceptors, analgesia, nimesulide, celecoxib, diclofenac, ibuprofen, dorsal 
root ganglia
Introduction
Nimesulide, celecoxib, diclofenac, and ibuprofen are nonsteroidal anti-inflammatory 
drugs (NSAIDs) in general use for the treatment of mild–moderate pain, acting mostly 
via cyclooxygenase (COX)-1/-2 inhibition, but also via other mechanisms, only 
partially identified. The anti-inflammatory and analgesic actions of these drugs go 
beyond COX inhibition, affecting a broad range of pain and inflammatory mediators 
and intracellular pathways, acting in a multifactorial fashion.1–4 Paracetamol is largely 
used as an analgesic and antipyretic, which, because of its lesser anti-inflammatory 
activity and poorer inhibition of COX-1 and COX-2,5,6 has not traditionally been 
considered a NSAID. This is despite recent recognition of its effects as a substrate 
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and inhibitor of the peroxidase function of COX-1 and 
COX-2 (which are stronger on the latter).7,8
In a recent paper, we proposed that nimesulide and 
paracetamol may exert novel mechanisms of action, likely 
relevant for their analgesic action, by modulating protein 
kinase C epsilon (PKCε) and substance P (SP) in the 
peripheral sensory neurons.9 In the present paper, we extend 
a similar analysis to other NSAIDs in general use.
PKCε has a crucial role in sensitizing peripheral neurons 
to painful stimuli leading to the sensitization of transient 
receptor potential vanilloid 1 (TRPV1) and other nociceptor-
specific ion channels. Translocation can be easily visualized 
with immunocytochemistry.9–13 Inhibition of translocation 
by nimesulide – and by paracetamol to a lesser extent – has 
been recently proposed by our group as a novel analgesic 
mechanism activated by these drugs.9
SP – a neuropeptide derived from the preprotachykinin 
(PPT)-A gene produced in a subset of peptidergic nociceptive 
neurons located in the dorsal root ganglia (DRGs) and 
trigeminal ganglia14 – is required for experiencing moderate 
to intense pain.15 Centrally, SP is released in the superficial 
laminae of the spinal dorsal horn, where it participates in 
the transmission of noxious stimuli.16 Further, when released 
from peripheral nerve endings, SP is an important mediator 
of neurogenic inflammation, together with other peptides,17–19 
and is involved in nociceptor sensitization, hyperalgesia, and 
allodynia following tissue injury.19,20 In this paper, we report 
on the modulation of SP synthesis and release by widely 
used analgesic and anti-inflammatory drugs. In relation 
to this, we have previously demonstrated that nimesulide 
significantly reduces the synovial fluid concentrations of SP 
in patients with knee osteoarthritis and, more recently, that 
nimesulide decreases synthesis and release of SP in cultured 
DRG neurons.9
Materials and methods
Drugs
The following anti-inflammatory/analgesic drugs were 
used in this study: nimesulide (Helsinn Healthcare, 
Lugano, Switzerland) and ibuprofen, celecoxib, diclofenac, 
and paracetamol (all obtained from Sigma-Aldrich, 
Milan, Italy).
DRG cultures of sensory neurons
Sprague Dawley rats (aged 14–21 days old) were sacrificed 
following total anesthesia according to European and Italian 
legislation, following protocols according to the guidelines 
of the Committee for Research and Ethical Issues of the 
International Association for the Study of Pain.21 Experimental 
procedures and research project were approved by local 
institutional animal care and use committee. DRGs were 
extracted and digested with 0.125% collagenase (Worthington 
Biochemical, Freehold, NJ, USA) for 60 minutes at 37°C, 
then dissociated with gentle trituration and allowed to attach 
onto glass coverslips or Petri dishes pretreated with 10 µg/mL 
 poly-l-lysine. Glass coverslips were also treated with 20 µg/mL 
laminin (Sigma-Aldrich). The culture medium – Dulbecco’s 
modified Eagle’s medium (DMEM) – was added with 
1.5 µg/mL cytosine 1-d-arabinofuranoside  (Sigma-Aldrich), 
10% fetal bovine serum (FBS), 1% L-glutamine, 1% penicillin/
streptomycin (Invitrogen, San Diego, CA, USA) as previously 
described.22 For the immunocytochemistry experiments, the 
medium also contained 100 ng/mL nerve growth factor (7s; 
Sigma-Aldrich) to increase bradykinin (BK)- and thrombin 
(THR)-receptor expression.12,23
Immunocytochemistry
The subcellular localization of the epsilon isoform of 
protein kinase C (ie, PKCε) was investigated as previously 
described.9,13,24 In brief, rat DRG neurons cultured for 2–3 days 
were rapidly exposed to BK (at 1 µM concentration) or THR (at 
100 nM concentration) for 30 seconds, then fixed for 10 minutes 
at room temperature with paraformaldehyde (4% formaldehyde 
and 4% sucrose, dissolved in phosphate-buffered saline [PBS]/
distilled water 2:1). The concentrations of BK and THR in 
some experiments were reduced to 10 nM to test the effects of 
drugs on non-saturating concentrations of stimulants inducing 
translocation. Dimethyl sulfoxide was used to prepare stock 
solutions of NSAIDs and paracetamol. The final concentration 
of dimethyl sulfoxide applied to cells was always lower than 
1:1000. Cells were treated with 10 µM of the tested drug 
for 2 hours before stimulation with THR and BK. As there 
are pharmacokinetic differences between paracetamol and 
nimesulide that lead to a higher plasma concentration of free 
paracetamol in clinical treatment, paracetamol was also tested 
at 100 µM. Fixed cells were washed three times with PBS and 
0.1% fish-skin gelatin, treated with Triton™ X-100 (0.2% 
in PBS) for 30 minutes at room temperature, and incubated 
at 4°C for 8–12 hours with an affinity-purified polyclonal 
antibody anti-PKCε10 diluted 1:1000 in PBS-T/gelatin (PBS 
with 0.05% Triton X-100). Coverslips were thoroughly rinsed 
then stained for 1 hour at room temperature with goat anti-
rabbit immunoglobulin G conjugated to Alexa Fluor® 488 
(1:200; Invitrogen), washed three times in PBS/gelatin, and 
analyzed using a confocal microscope (Leica SP2, Leica, 
Switzerland). Activation of PKCε downstream of Gq-coupled 
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membrane receptors leads to translocation from the cytoplasm 
to the neuronal cell membrane (see Figure 1). Translocation 
was assessed by measuring fluorescence intensity along a 
line across the cell, avoiding the nucleus (for details, see 
Cesare et al10). Neurons in which peak intensity at the cell 
membrane was at least 2.0× greater than the mean of cytoplasm 
intensity were considered positive.
Culture stimulation and drug treatment
At Day 2/3 in vitro, cultures were stimulated using a cocktail 
of inflammatory/pro-algesic mediators (termed “inflammatory 
soup” [IS]) composed of 100 nM THR, 1 µM BK, 100 nM 
endothelin-1, 25 mM potassium chloride, dissolved in culture 
medium (DMEM + 10% FBS) as previously described.9 When 
required, at a concentration of 10 µM, each of the drugs to be 
tested was pre-applied to cultures before treatment with IS 
for the time considered appropriate to be fully effective (see 
“Results”). Paracetamol was also tested, but at a concentration 
of 100 µM. Cells were then stimulated with IS with/without 
drugs for either 70 minutes or 36 hours. At the end of the 
incubation times, media and/or cells were separately stored 
and processed as described following.
Measurement of SP and prostaglandin E2 
(PGE2) in culture media
SP was measured by radioimmunoassay (RIA) according 
to methods previously described and validated using an 
antibody raised in rabbit against synthetic antigen mimicking 
an epitope in the C terminal of SP.25,26 I125-SP was purchased 
from PerkinElmer (Monza, Italy). Culture media pH was 
lowered with 1 N acetic acid before the procedure. Sensitivity 
of the RIA was 10 pg/tube and the intra- and inter-assay 
variation coefficients were 8% and 11%, respectively.
Quantitative determination of PGE
2
 was performed by 
enzyme immunoassay (EIA) using a commercially available 
EIA kit (Cayman Chemical, Ann Arbor, MI, USA) with a 
sensitivity of 15 pg/mL.
RNA isolation and real-time 
polymerase chain reaction (PCR)
This was undertaken as outlined in Vellani et al:9
Total RNA from DRG cells was purified using TRIzol 
reagent (Invitrogen, Life Technologies, San Giuliano 
Milanese, Italy). Cells were lysed directly in the culture 
dish, according to the manufacturer’s instructions and 
resuspended in 8 µL of formamide. After purification, total 
RNA concentrations were determined from the sample 
absorbance value at 260 nm. 3000 ng of total RNA were 
treated with DNase (DNA-free-Ambion) to avoid false-
positive results due to amplification of contaminating 
genomic zDNA. First strand cDNA was synthesized from 
1000 ng of total RNA in a final volume of 20 µL using 
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Figure 1 Protein kinase C epsilon (PKCε) translocation induced by bradykinin (BK) 
and thrombin (ThR) is inhibited by nimesulide and paracetamol, but not by other 
nonsteroidal anti-inflammatory drugs (NSAIDs) tested. (A and B) Confocal optical 
sections of cultured sensory neurons treated with ThR (100 nM) for 30 seconds 
and subsequently fixed and stained for PCKε with a polyclonal specific antibody: 
(A) typical neuron showing no response; (B) typical ThR-responsive neuron with 
translocation of PKCε to the plasma membrane. Neurons treated with 1 µM BK for 
30 seconds had identical appearance. Neurons not treated with BK or ThR showed 
no sign of translocation. Scale bar 5 µm. (C) PKCε translocation in cultured dorsal 
root ganglion neurons induced by THR (100 nM for 30 seconds), quantified as the 
percentage of neurons showing a clear edge. Translocation induced by ThR was 
significantly reduced in the presence of nimesulide and paracetamol, while celecoxib, 
diclofenac, and ibuprofen were ineffective. All drugs were applied for 2 hours at a 
concentration of 10 µM before treatment with ThR. (D) The effects of NSAIDs and 
paracetamol on translocation induced by BK (1 µM for 30 seconds) were largely 
similar and nimesulide was significantly stronger than paracetamol (P , 0.05).
Notes: Values represent means ± standard error of the mean of data from six to 
eight separate cultures. *P , 0.05 versus controls (analysis of variance followed by 
Bonferroni’s t-test).
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M-MLV RT (Moloney Murine Leukemia Virus Reverse 
Transcriptase; Invitrogen, San Giuliano Milanese, Italy). 
cDNA (2 µL) was subjected to real-time quantitative 
PCR using ABI PRISM 7000 (Applied Biosystems, 
Forster City, CA). TaqMan PCR was performed in 25 µL 
volumes using Real Master Mix Probe ROX (Eppendorf, 
Hamburg, Germany). Custom probes for preprotachykinin 
(PPT, Genbank accession number M15191) and GAPDH 
[glyceraldehyde 3-phosphate dehydrogenase] (Genbank 
accession number AF106860) were prepared by Applied 
Biosystem. The probes were designed to span an intron in 
order to avoid potential amplification of genomic DNA in 
the analyzed samples.9,25 The probes were labeled at the 5′ 
end with 6-carboxy fluorescein (FAM) and at the 3′ end 
with 6-carboxy-tetramethyl rhodamine (TAMRA). All 
PCR assays were performed in duplicate. Before using the 
∆∆CT method for relative quantification, we performed a 
validation experiment to demonstrate that the efficiencies 
of the two different probes (target and reference) are equal. 
The reaction conditions were as follows: 95°C for 2 min, 
followed by 40 cycles at 95°C for 15 s (denaturation) and 
60°C for 1 min (annealing and elongation). As controls, 
we used the reaction mixture without the cDNA. Threshold 
cycle numbers (CT) were determined with an ABI PRISM 
7000 Sequence Detection System (version 1.1 software) and 
transformed using the ∆CT (2-∆∆CT) comparative method. 
Gene-specif ic expression values were normalized to 
expression values of GAPDH (endogenous control) within 
each sample. The levels of preprotachykinin were expressed 
relative to the calibrator value control cells. Relative 
quantif ication was performed using the comparative 
method. The amount of target, normalized to an endogenous 
reference and relative to a calibrator, is given by 2-∆∆CT. 
Briefly, the ∆CT value is determined by subtracting the 
average GAPDH CT value from the average PPT CT in the 
same sample. The calculation of ∆∆CT involves subtraction 
of the ∆CT calibrator value.
Statistical analysis
Data were analyzed by analysis of variance followed by 
Bonferroni’s t-test for multiple comparisons. An effect was 
considered significant if the P value was ,0.05.
Results
Modulation of PKCε translocation
In sensory neurons,  the activation of PKCε  by 
inflammatory mediators (or, artificially, by phorbol esters) 
is followed by its translocation to the plasma membrane. 
Translocation occurs rapidly and can be directly observed 
with immunocytochemistry (Figure 1A and B).9,12,13,23 In 
this study, PKCε activation was quantified as the percentage 
of neurons showing membrane translocation. This method 
allowed for the measurement of reproducible time-course and 
dose–response curves, as previously shown.12,13 Following 
exposure to 100 nM THR or 1 µM BK, sufficient to saturate 
the specific receptors, maximum translocation was always 
observed.10,11 Application times longer than 30 seconds 
would allow PKCε to become internalized into perinuclear 
vesicles, decreasing the number of translocation-positive 
neurons, as has been shown previously.10,11,13 As maximum 
percentage of translocation was reliably measured at 
30 seconds of exposure to the agonist concentrations 
mentioned, as in previous studies,9 these parameters were 
used for most of our work, with the exception of some 
experiments with nimesulide and paracetamol, in which we 
tested a roughly half-maximal agonist concentration (10 nM 
applied for 30 seconds in the case of both stimulants).10,11,13 
THR applied on cultures for 30 seconds at 100 nM and 
BK applied on cultures for 30 seconds at 1 µM, triggered 
translocation in 17.8% ± 1.0% and 26.3% ± 1.2% of 
DRG neurons, respectively, in this set of experiments, a 
percentage similar to that previously obtained;9 THR and 
BK applied for 30 seconds at 10 nM triggered translocation 
in 8.8% ± 0.9% and in 14.4% ± 0.7% of DRG neurons, 
respectively.
As shown in Figure 1, when compared with neurons 
pretreated with vehicle solution, the percentage of neurons 
in which THR (A) and BK (B) induced translocation was 
significantly decreased to 11.1% ± 1.4% and 13.6% ± 1.2%, 
respectively, by a 2-hour pre-application of 10 µM nimesulide 
(P , 0.001). This was similar to the decrease obtained in 
previous work,9 in which a different set of experiments 
was used. Therefore, nimesulide reduced the translocation 
induced by saturated concentrations of THR and BK by ∼38% 
and ∼48%, respectively. This percentage was largely similar 
to that achieved in experiments in which 10 µM nimesulide 
was pre-applied onto neurons stimulated with 10 nM THR 
and BK, which produced translocation in 5.3% ± 0.8% and 
8.2% ± 0.5% of neurons, respectively (about ∼40% and 
43% reduction, respectively). In contrast, the application 
of the NSAIDs celecoxib, diclofenac, and ibuprofen (all at 
10 µM concentration, also pre-applied for 2 hours) on THR- 
and BK-induced translocation did not cause a significant 
variation when compared with control experiments. 
Paracetamol (10 µM), also as previously observed,9 inhibited 
translocation by 100 nM THR and 1 µM BK to 13.4% ± 0.5% 
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and 16.6% ± 0.7%, respectively, with a reduction of ∼25% 
and ∼37%, respectively. A larger concentration of paracetamol 
(100 µM) was tested on translocation by 100 nM THR 
and 1 µM BK causing a reduction of ∼27% and ∼34%, 
respectively, versus the respective controls. We concluded 
that the maximal paracetamol effect on translocation was 
achieved at a concentration of 10 µM.
The reduction in translocation-positive neurons caused 
by nimesulide and paracetamol was not accompanied by 
an increase in neurons showing PKCε internalization after 
translocation, as such neurons comprised less than 1% of the 
total number of translocated neurons, both in the control and 
drug-treated neurons. All experiments were repeated between 
six and twelve times.
Longer applications of NSAIDs or paracetamol at 10 µM 
(increased from 2 hours to overnight) before stimulation with 
THR or BK had no significant effect (results not shown).
Effects of drugs on PPT mRNA synthesis
SP is derived from its precursor, PPT. PPT mRNA levels were 
assessed in DRG cultures with real-time PCR, as shown in 
Figure 2, in which measurements are expressed as relative 
mRNA levels of PPT normalized to GAPDH. Gene specific 
expression values are normalized to GAPDH (endogenous 
control) within each sample (∆CT). Each ∆CT is transformed 
using the ∆CT (2-∆∆CT) comparative method. In this way 
expression values of control cultures are arbitrary considered 
as 1, and treatment values are expressed as fold increase 
in relation to control. In basal conditions approximately 
60 hours after plating, measurable PPT mRNA levels could 
be detected. Basal amounts of PPT mRNA were significantly 
decreased by 36-hours’ exposure to nimesulide, while they 
remained unchanged after 36-hours of treatment with other 
tested NSAIDs and paracetamol (all at 10 µM).
Stimulation with IS raised mRNA amounts by 
approximately 2.6-fold when compared with the control 
(Figure 2B), consistent with previous similar experiments.9 
Drug treatments (all at 10 µM) were added on cells 10 minutes 
before stimulation with IS and maintained in culture for 
36 hours. Nimesulide, celecoxib, and diclofenac significantly 
decreased the increase of PPT mRNA expression induced 
by the IS with similar levels of efficacy, and paracetamol 
was somewhat less, although still significantly, effective. In 
contrast, ibuprofen had no effect.
Effects on basal and stimulated SP release
Concentrations of SP released by cultured sensory neurons in 
culture medium were measured by RIA (see “Materials and 
methods”). After 24 hours in culture, individual coverslips 
from the same cultures were treated either with vehicle 
or IS. Separate IS-treated coverslips contained either one 
of the NSAIDs investigated, paracetamol (all at 10 µM) or 
vehicle solution, giving a total of seven conditions. Coverslips 
were pretreated with the same concentration of the drugs 
investigated for 10 minutes before addition of IS, and 
coverslips containing only IS were pretreated for the same 
time with vehicle medium. Thus, in these experiments, the 
effect of the drugs was tested on the IS-stimulated release 
of SP and not on the basal release which was not modified 
by nimesulide or paracetamol (see Vellani et al9) or any of 
the drugs tested in this paper (data not shown). In Figure 3, 
all results shown are normalized to basal (vehicle-only) 
levels. The treatments lasted for either 70 minutes or 
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Figure 2 Modulation of basal and induced preprotachykinin (PPT) mRNA expression 
in cultured rat dorsal root ganglion cells by nonsteroidal anti-inflammatory drugs 
(NSAIDs) and paracetamol. (A) Basal expression of PPT mRNA was significantly 
reduced by nimesulide but was unchanged by treatment with other NSAIDs or 
paracetamol (all at 10 µM). (B) Nimesulide, paracetamol, celecoxib, and diclofenac 
significantly decreased upregulation of PPT mRNA expression induced by the 
inflammatory soup, while ibuprofen was ineffective. 
Notes: The amount of PPT is normalized to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDh) levels by subtracting the average GAPDh CT value 
from the average PPT CT value then applying the comparative method (2-∆∆CT) 
using untreated cells as calibrator (controls). All drugs were applied at 10 µM for 
36 hours. Values represent means ± standard error of the mean of four to six 
experiments. *P , 0.05 versus respective controls (analysis of variance followed by 
Bonferroni’s t-test).
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36 hours (Figure 3A and B, respectively), then the medium 
was collected and stored at −80°C before SP quantitation. 
At 70 minutes after exposure to the IS, nimesulide was the 
only compound found to be capable of significantly reducing 
SP release. At 36 hours following exposure to the IS, 
nimesulide, celecoxib, and diclofenac significantly reduced 
the IS-induced release of SP, while reductions caused by 
paracetamol and ibuprofen were not statistically significant. 
Paracetamol was also tested at a concentration of 100 µM; at 
this concentration, paracetamol did not significantly reduce 
stimulated SP release in medium at 70 minutes or 36 hours 
(n = 4, data not shown).
Effects on PGE2 release in medium
PGE
2
 was measured in cultures of sensory neurons by 
EIA.25,27 Little, if any, PGE
2
 was measured in the medium, 
the only traces being present in the FBS added to the DMEM 
(see “Materials and methods”). After 24 hours in culture, the 
medium was removed and the cells were treated either with 
vehicle or IS, with or without NSAIDs or paracetamol (all at 
10 µM). At 70 minutes or 36 hours of treatment, the medium 
was removed from the cultures and the PGE
2
 released 
was measured. The PGE
2
 released by unstimulated DRG 
cultures in this set of experiments was 143 ± 22.8 pg/mL 
after 70 minutes and 492 ± 18.6 pg/mL after 36 hours. 
PGE
2
 amounts significantly increased in comparison with 
the control by 70 minutes’ or 36 hours’ treatment with the 
IS: compared with the control, 70 minutes’ stimulation 
augmented PGE
2
 concentrations by about 2.3-fold, while the 
increase was about 10.5-fold after 36 hours (see Figure 4B 
and D).
Treatment with NSAIDs (10 µM; applied for 70 minutes) 
strongly inhibited both basal (Figure 4A) and IS-stimulated 
PGE
2
 levels (Figure 4B) released in the medium compared 
with untreated cells, and not only inhibited the IS effect, but 
also reduced the amount of PGE
2
 released to concentrations 
even lower than the basal level (Figure 4B). Similarly, 
36 hours’ treatment with all NSAIDs reduced basal and 
stimulated PGE
2
 down to levels lower than those present in 
the medium in unstimulated cultures (Figure 4C and D).
Paracetamol at 10 µM had significant effects on basal 
and IS-induced PGE
2
 release at both 70 minutes and 
36 hours. However, the inhibition of IS-induced PGE
2
 
release, in particular at 36 hours, was only partial, as PGE
2
 
was higher than in cells that had not received IS treatment. 
Paracetamol at 100 µM also exerted only partial inhibition 
on basal and IS-induced PGE
2
 release, both at 70 minutes 
and 36 hours. Basal PGE
2
 release was reduced by ∼28% 
and ∼42% at 70 minutes and 36 hours, respectively, by 
10 µM paracetamol (see Figure 4), and by ∼54% and ∼78%, 
respectively, by 100 µM paracetamol. IS-stimulated PGE
2
 
release was inhibited by ∼46% and ∼62% by 10 µM 
paracetamol at 70 minutes and 36 hours, respectively, and 
by ∼35% and ∼62% by 100 µM paracetamol at 70 minutes 
and 36 hours, respectively.
Discussion
The importance of PKCε activation in sensory neurons 
in peripheral mechanisms of hyperalgesia and allodynia 
has been studied in many papers and largely agreed upon. 
Cesare et al10 first showed that the increase (sensitization) of 
the heat-gated current induced by BK in cultured nociceptors 
is due to PKCε and, in the following years, a large number 
of studies validated the important role of this isoform in 
inflammatory hyperalgesia and allodynia in cellular and 
behavioral models.22,28–30 PKCε is highly expressed in 
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Figure 3 Modulation by nonsteroidal anti-inflammatory drugs and paracetamol of 
substance P (SP) release from dorsal root ganglion neurons after 70 minutes (A) and 
36 hours (B) of treatment with inflammatory soup. 
Notes: At 70 minutes, only nimesulide significantly reduced SP release, while 
over longer times celecoxib and diclofenac were also effective. Values are 
means ± standard error of the mean of four to six experiments and are expressed 
as % of control cultures. *P , 0.05 versus respective inflammatory soup-stimulated 
cultures (analysis of variance followed by Bonferroni’s t-test).
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small-diameter sensory neurons, in which it is essential for 
chronic hyperexcitability; nevertheless, when blocked, it 
has only negligible effects on other sensory or non-sensory 
functions.30 Therefore, PKCε is currently considered a 
well-validated mediator of chronic pain, both in inflammatory 
and neuropathic models,31,32 and as a new and potentially 
important target for therapeutic treatment.
In this context, the reported inhibition of PKCε 
translocation by nimesulide and paracetamol (previously 
reported for both drugs at 10 µM9 and in the present paper 
by paracetamol at 100 µM) appears to be highly relevant to 
properly understand the pharmacological actions of these 
drugs. However, it is interesting to notice that, as shown in 
Figure 1, not all NSAIDs inhibit PKCε: celecoxib, diclofenac, 
and ibuprofen did not interfere with translocation by BK or 
THR, therefore their analgesic actions cannot be due to any 
effect on translocation.
Prostaglandins (PGs) are normally produced in large 
quantities after the exposure of cultured sensory neurons 
to BK, THR, and IS. They can be produced not only by 
nociceptive neurons themselves, which express COX-
1,12,33 but also by satellite cells and Schwann cells, which 
are present in large numbers together with neurons in 
DRG cultures. These cells express most receptors for the 
same inflammatory mediators expressed by neurons, and 
release PGs and many other mediators.34,35 In principle, 
inhibition of PG synthesis, in particular of PGE
2
, which 
can activate PKCε,24 might be responsible for the effect of 
NSAIDs, as previously hypothesized.9 However, in this study, 
we demonstrated that the other NSAIDs at the concentrations 
tested – which, like nimesulide, would strongly inhibit 
COX (Figure 4) – did not inhibit translocation. Therefore, 
an indirect effect on translocation via COX inhibition is 
unlikely, and some more specific inhibitory mechanisms on 
translocation by nimesulide and paracetamol, in comparison 
to other NSAIDs, must be responsible for the effects 
observed.
Nimesulide’s and paracetamol’s inhibitory effects are 
basically identical both on BK- and THR-induced translocation, 
suggesting that these drugs affect other mechanisms of 
the intracellular pathway leading to translocation rather 
than specifically interacting with BK and THR membrane 
receptors – possibly directly PKCε itself or the interaction of 
PKCε with its specific receptors for activated PKC.36
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SP is one of the mediators of inflammatory pain due to 
a complex pattern of local changes, including the synthesis 
and release of many pro-nociceptive and pro-inflammatory 
mediators. These mediators lower nociceptive thresholds 
and increase neuronal membrane excitability, leading to 
hyperalgesia and allodynia.37,38 Following noxious stimulation, 
SP is exocitosed through a very complex mechanism involving 
several important events including calcium inflow, 1-4-5 inositol 
triphosphate-mediated intracellular calcium release, extracellular 
signal-regulated kinases, protein kinase A, and COX activation 
and release of PGs. In the central nervous system, SP has an 
important function in the sensitization of spinal neurons, while, 
in the peripheral nervous system, it produces vasodilatation, 
decreases nociceptive threshold, and participates in neurogenic 
inflammation.17 In the immune system, SP can directly induce 
the chemotaxis of macrophages and monocytes and the synthesis 
of several pro-inflammatory cytokines.26,39,40 These mechanisms 
play a role in the diffusion of sensitization leading to secondary 
hyperalgesia. Therefore, modulation of spinal and peripheral SP 
extracellular levels appears to be a crucial control factor for the 
pain threshold in inflammatory hyperalgesia.
In our experiments, the increased PPT synthesis 
activated by IS was significantly reduced by the NSAIDs 
nimesulide, diclofenac, and celecoxib, but not by ibuprofen 
or paracetamol, while unstimulated level of synthesis was 
significantly affected only by nimesulide (Figure 2).
Moreover, modulation of SP release is not part of the 
effects of paracetamol and ibuprofen. In the case of the latter, 
this suggests that if indirect mechanisms occur, they may 
not involve COX inhibition, as ibuprofen is a potent general 
COX inhibitor, as shown in Figure 4.
Considering the models used in our experiment and the 
rapidity of the effect, the inhibition of SP release by nimesulide 
is probably caused by a direct effect on nociceptive neurons. In 
contrast, the inhibition of SP release by celecoxib and diclofenac 
took longer to occur, thus may involve indirect mechanisms, one 
of which may be their well-known COX inhibition, which leads 
to lower PG production. However, the observation that ibuprofen 
is unable to affect SP seems to rule out the possibility that PGs 
could be the main mediators involved in the effects. In addition, 
we previously demonstrated that paracetamol is also effective 
in reducing PG synthesis in DRG cultures, while being only 
partially able to modulate SP.9 However, a main pharmacological 
difference between ibuprofen and the other NSAIDs studied is 
that ibuprofen has a higher specificity for COX-1. Since both 
COX-1 and COX-2 are active in DRG sensory neurons as well 
as in satellite cells and other cells of inflamed tissues, further 
studies are needed to understand the role of the two enzyme 
isoforms. Nevertheless, other indirect mechanisms activated by 
other intermediate mediators cannot be ruled out.
It has been recently reported that TRPV1 channel activity 
(and subsequent calcium inflow) is a potent trigger of SP 
production and release.41 As TRPV1 sensitization is caused 
by PKCε-dependent phosphorylation, the likelihood that 
NSAIDs may decrease SP via PKCε translocation inhibition 
can be conceived. Conversely, the binding of SP to neurokinin 
1 receptors in nociceptors sensitizes TRPV1 via PKCε 
activation.42 Therefore, a positive feedback mechanism can 
be hypothesized, in which SP, PGs, TRPV1, and PKCε act 
together to produce hyperalgesia during inflammation.
However, one cannot exclude the possibility that the 
inhibition of translocation and the reduction in SP release are 
independent events controlled by unrelated mechanisms. In 
any case, the effects of celecoxib, diclofenac, and nimesulide 
on numerous important related mediators can be useful 
not only to control acute hyperalgesia but also to avoid its 
progression to chronic pain.
Conclusion
Our data help to clarify the range of pharmacological effects 
of widely used NSAIDs and of paracetamol in their use as 
analgesics. We are aware that it is not possible to claim that the 
effects described would occur to a quantitatively similar extent 
in human patients. In fact, considering the pharmacokinetics, 
in clinical treatment, the plasma concentrations of free drug 
would possibly be lower than the ones used in this study (as 
well as in other studies) in vitro, as the aim was to show the 
maximum effect obtainable in our in vitro models. Nevertheless, 
our results suggest that NSAIDs generally and nimesulide in 
particular are drugs with multifactorial modes of action with 
an increasing number of novel and interesting targets.
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